KPTI
Karyopharm Therapeutics Inc
1.80$
-3.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +96.3% | +13.1% | -0.6% | +3.1% | +32.5% | -0.2% | -18.8% | -21.3% | -14.7% | -35.8% | -133.5% | |
| – | +19.8% | +30.6% | -8.4% | -15.3% | -11.5% | +59.6% | +22.0% | +18.9% | -38.7% | -15.1% | -23.7% | |
| – | +19.4% | +30.6% | -8.4% | -15.3% | -11.5% | +58.4% | +52.9% | -5.2% | – | – | – | |
| – | -58.8% | -75.3% | +3,239.6% | -100.5% | – | – | -1,810.1% | – | – | -101.0% | – | |
| – | -50.0% | -95.1% | -11.4% | +3,711.3% | -91.3% | -29.6% | +3,839.3% | -97.9% | -100.0% | – | -100.0% | |
| – | +35.5% | – | -30.4% | -729.3% | – | -168.4% | – | -173.5% | – | +1,102.4% | -54.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.5% | +2.3% | +36.2% | +310.1% | +28.0% | +128.8% | -63.7% | +6.2% | – | – | – | |
| – | – | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | -67.6% | |
| – | -18.1% | -44.8% | +48.0% | +317.3% | -60.7% | +38.4% | -57.2% | +163.1% | -99.4% | +3,605.2% | -27.8% | |
| – | – | – | – | +154.7% | -75.7% | -447.8% | – | -155.9% | – | – | -120.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.